Warrants of series TO2 have been recalculated and the subscription price when exercising the warrants in Pharmacolog has been set to SEK 0.18 and the exercise period starts on October 4, 2023.
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, BELARUS, HONG KONG, JAPAN, CANADA, NEW ZEALAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, OR IN ANY OTHER JURISDICTION WHERE THE DISTRIBUTION OF THIS PRESS RELEASE WOULD BE UNLAWFUL OR WOULD REQUIRE ACTION OTHER THAN THAT REQUIRED BY SWEDISH LAW.
Pharmacolog i Uppsala AB ("Pharmacolog" or the "Company") completed a rights issue of units on Nasdaq First North Growth Market in September 2022. Each unit consisted of two (2) shares of series B and one (1) warrant of
